All In Biotech

Drug Trial Radar · NCT05620836

A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)

A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa

Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 619 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

619

Actual

Start

Feb 22, 2023

Primary completion

Jan 7, 2025

Study completion Nov 21, 2025

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
Nov 17, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of Povorcitinib (INCB054707) in participants with moderate to severe Hidradenitis Suppurativa (HS) over a 12-week placebo-controlled period, followed by a 42-week extension period.

Conditions

  • Hidradenitis Suppurativa (HS)

Interventions

  • PovorcitinibDrug

    Oral, Tablet

  • PlaceboDrug

    Oral, Tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Achieved Hidradenitis Suppurativa Clinical Response 50 (HiSCR50) at Week 12Time frame: Baseline; Week 12

Locations

101 sites in 11 countries. Site status is shown where the registry gives one.

  • Investigative Site US240

    Scottsdale, Arizona

  • Investigative Site US237

    Scottsdale, Arizona

  • Investigative Site US214

    Arkansas City, Arkansas

  • Investigative Site US242

    Fayetteville, Arkansas

  • Investigative Site US223

    Los Angeles, California

  • Investigative Site US226

    San Diego, California

  • Investigative Site US222

    San Francisco, California

  • Investigative Site US233

    Washington D.C., District of Columbia

  • Investigative Site US228

    Brandon, Florida

  • Investigative Site US227

    Margate, Florida

  • Investigative Site US204

    Miami, Florida

  • Investigative Site US236

    Miami, Florida

  • Investigative Site US200

    Ocala, Florida

  • Investigative Site US201

    Tampa, Florida

  • Investigative Site US220

    West Dundee, Illinois

  • Investigative Site US206

    Indianapolis, Indiana

  • Investigative Site US241

    Iowa City, Iowa

  • Investigative Site US209

    Louisville, Kentucky

  • Investigative Site US207

    Metairie, Louisiana

  • Investigative Site US229

    New Orleans, Louisiana

  • Investigative Site US224

    Baltimore, Maryland

  • Investigative Site US208

    Beverly, Massachusetts

  • Investigative Site US221

    Quincy, Massachusetts

  • Investigative Site US213

    Detroit, Michigan

  • Investigative Site US217

    Waterford, Michigan

  • Investigative Site US212

    Minneapolis, Minnesota

  • Investigative Site US239

    Omaha, Nebraska

  • Investigative Site US230

    Hightstown, New Jersey

  • Investigative Site US202

    New York, New York

  • Investigative Site US210

    Rochester, New York

  • Investigative Site US205

    Chapel Hill, North Carolina

  • Investigative Site US215

    Bexley, Ohio

  • Investigative Site US203

    Columbus, Ohio

  • Investigative Site US232

    Murfreesboro, Tennessee

  • Investigative Site US235

    Arlington, Texas

  • Investigative Site US218

    Bellaire, Texas

  • Investigative Site US238

    Pflugerville, Texas

  • Investigative Site US234

    San Antonio, Texas

  • Investigative Site AU205

    Kogarah, New South Wales, Australia

  • Investigative Site AU203

    Kotara, New South Wales, Australia

Showing 40 of 101 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.